Could a weight-loss drug curb meth addiction? new trial aims to find out.
NCT ID NCT07204249
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tests whether semaglutide (Wegovy), a drug used for diabetes and weight loss, can help people reduce or stop using methamphetamine. It involves 162 adults with moderate to severe methamphetamine use disorder who will receive either the drug or a placebo over 12 weeks. Researchers will measure changes in meth use through urine tests and self-reports to see if the treatment is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE-DEPENDENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.